Laboratory and Bio-Pharma Technology Expo Osaka, Japan

[Exhibition Overview]

    The exhibition is abbreviated as BioPharma Expo in English. It is a professional event dedicated to the biopharmaceutical R&D sector, covering multiple segments including R&D technology, manufacturing technology, and related contract services. It attracts industry professionals, exhibitors, and visitors from around the world.

[Exhibition Highlights and Scale]

    This edition of the exhibition brings together 450 pharmaceutical companies from around the globe, which will jointly explore the latest development trends in antibody drugs, cell therapy, and AI-driven R&D.

    Concurrent events include the PMDA Policy Forum and the Sino-Japanese Summit, helping participants seize the early opportunities in the Asian biopharmaceutical market.

[Industry Background]

    The global biopharmaceutical industry is currently in a phase of rapid development. Japan is the world's second-largest investor in biomedical R&D, and also the world's third-largest pharmaceutical and biotechnology market after the US and China. Its investment scale in R&D ranks second globally.

    In recent years, Japan's ageing population has deepened, driving the market demand for related industries to grow year by year. The Japanese government is also actively advancing pharmaceutical market reform policies, requiring the introduction of international new technologies and resources. The demand is particularly prominent in areas such as new drug R&D and testing, and stem cell regenerative medicine.